DE69005993T2 - Verfahren zur Herstellung eines Ranitidin-Harz-Absorbates. - Google Patents

Verfahren zur Herstellung eines Ranitidin-Harz-Absorbates.

Info

Publication number
DE69005993T2
DE69005993T2 DE90312263T DE69005993T DE69005993T2 DE 69005993 T2 DE69005993 T2 DE 69005993T2 DE 90312263 T DE90312263 T DE 90312263T DE 69005993 T DE69005993 T DE 69005993T DE 69005993 T2 DE69005993 T2 DE 69005993T2
Authority
DE
Germany
Prior art keywords
resin
ranitidine
absorbate
production
adsorbate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90312263T
Other languages
English (en)
Other versions
DE69005993D1 (de
Inventor
Stephen John Douglas
Fiona Ruth Bird
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE69005993D1 publication Critical patent/DE69005993D1/de
Application granted granted Critical
Publication of DE69005993T2 publication Critical patent/DE69005993T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Furan Compounds (AREA)
DE90312263T 1989-11-10 1990-11-09 Verfahren zur Herstellung eines Ranitidin-Harz-Absorbates. Expired - Fee Related DE69005993T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898925484A GB8925484D0 (en) 1989-11-10 1989-11-10 Process

Publications (2)

Publication Number Publication Date
DE69005993D1 DE69005993D1 (de) 1994-02-24
DE69005993T2 true DE69005993T2 (de) 1994-05-05

Family

ID=10666117

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90312263T Expired - Fee Related DE69005993T2 (de) 1989-11-10 1990-11-09 Verfahren zur Herstellung eines Ranitidin-Harz-Absorbates.

Country Status (9)

Country Link
EP (1) EP0431759B1 (de)
JP (1) JPH03206037A (de)
AT (1) ATE99925T1 (de)
AU (1) AU6652790A (de)
CA (1) CA2029667A1 (de)
DE (1) DE69005993T2 (de)
DK (1) DK0431759T3 (de)
ES (1) ES2047864T3 (de)
GB (1) GB8925484D0 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104042D0 (en) * 1991-02-26 1991-04-10 Abbott Lab Taste-masked buflomedil preparation
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
EP1467769B1 (de) * 2002-01-18 2008-05-28 Rohm and Haas Company Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens
GR1009069B (el) * 2015-01-05 2017-07-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838952A (en) * 1957-10-03 1960-06-22 Clinical Products Ltd Resin-drug compounds
FR1335502A (fr) * 1960-06-02 1963-08-23 Merck & Co Inc Nouveaux composés d'adsorption de la nicotinamide
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
GB1462356A (en) * 1973-07-10 1977-01-26 Beecham Group Ltd Pharmaceutical compositions
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it

Also Published As

Publication number Publication date
EP0431759B1 (de) 1994-01-12
DE69005993D1 (de) 1994-02-24
GB8925484D0 (en) 1989-12-28
ES2047864T3 (es) 1994-03-01
ATE99925T1 (de) 1994-01-15
DK0431759T3 (da) 1994-02-28
JPH03206037A (ja) 1991-09-09
CA2029667A1 (en) 1991-05-11
EP0431759A1 (de) 1991-06-12
AU6652790A (en) 1991-05-16

Similar Documents

Publication Publication Date Title
ATE116003T1 (de) Verfahren zur herstellung und reinigung von bernsteinsäure.
DE69201959T2 (de) Verfahren zur Herstellung von 6,12-Dihydro-6-hydroxy-cannabidiol und dessen Anwendung zur Herstellung von trans-delta-9-Tetrahydrocannabinol.
AT372695B (de) Verfahren zur herstellung eines waesserigen kalziumkarbonatpraeparates mit einem gehalt von 65 bis 80 gew.kalziumkarbonat
ATE24658T1 (de) Verfahren zur herstellung eines molkeproduktes.
DE59005902D1 (de) Verfahren zur Herstellung niederer, mehrwertiger Alkohole.
ATE122054T1 (de) Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates.
ATE123777T1 (de) Verfahren zur herstellung von (6s)- und (6r)- tetrahydrofolsäure.
DE69011880T2 (de) Verfahren zur Herstellung von L-Aminosäuren durch Fermentation.
EP0391393A3 (de) Verfahren zur Herstellung von Cefodizim-Dinatrium
DE59008170D1 (de) Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel.
ATE155781T1 (de) Verfahren zur herstellung von 2- hydroxytetrahydrofuran und 4-hydroxybutanal gemische
DE69016840D1 (de) Verfahren zur Herstellung eines lateralen Bipolartransistors.
ATE95041T1 (de) Verfahren zur herstellung eines nahrungsmittels durch koextrusion.
DE69217913T2 (de) Verfahren zur Aromatisierung von Milchschokolade
DE69005993D1 (de) Verfahren zur Herstellung eines Ranitidin-Harz-Absorbates.
DE68923260D1 (de) Verfahren zur Herstellung eines Derivates der 3,5,6-Trihydroxyhexansäure.
DE68923635D1 (de) Verfahren zur Herstellung von fester Lactulose.
DE3854266D1 (de) Verfahren zur Modifizierung eines Molekularsiebes.
DE69008547D1 (de) Verfahren zur Herstellung eines aromatischen Alkohols.
ATE110279T1 (de) Verfahren zur herstellung eines pertussis-toxin- toxoides.
DE58905649D1 (de) Verfahren zur Herstellung eines macerierenden Aspergillus-Enzyms.
DE69033833D1 (de) Verfahren zur Herstellung von Butantetracarbonsäure
ATE111457T1 (de) Verfahren zur herstellung von di-(p- glycidoxicyclohexyl)-methan.
ATE108204T1 (de) Verfahren zur herstellung von alkylmethylketonen.
ATE91123T1 (de) Verfahren zur kontinuierlichen herstellung von glyoxylsaeure.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee